Latest News - Acne

Monday, March 25, 2019

Biofrontera Acquires Cutanea Life Sciences

Biofrontera Inc., USA entered into an agreement to acquire all shares in Cutanea Life Sciences, Inc., USA through its subsidiary Biofrontera Newderm LLC as the acquirer, with Maruho Co., Ltd., Japan a…

Read the full story

Monday, March 11, 2019

Calling All Students: Ortho Dermatologics Now Accepting Applications for the 2019 Aspire Higher Scholarship Program

Ortho Dermatologics is accepting applications for its 2019 Aspire Higher scholarship program, which will award $90,000 total in scholarships to nine students who have been treated for a dermatologic c…

Read the full story

Thursday, March 07, 2019

New Mouse Model Validates How “Good” and “Bad” Bacteria Affect Acne

Researchers at University of California San Diego School of Medicine, Cedars-Sinai and UCLA have developed a new mouse model that closely resembles human acne by adding one new factor -- a synthetic…

Read the full story

Tuesday, March 05, 2019

Get to Know the Dermatology Hall of Fame's 2019 Inaugural Class of Inductees

The 10 individuals inducted into the Dermatology Hall of Fame’s 2019 Inaugural Class are: Albert Bernard Ackerman, M.D., the author of “Histologic Diagnosis of Inflammatory Skin Disease…

Read the full story

Friday, March 01, 2019

Study: Isotretinoin Does Not Raise Depression Risk

Isotretinoin is not an independent risk factor for depression in adult acne patients, finds new research presented at the 2019 American Academy of Dermatology (AAD) Annual Meeting in Washington. &l…

Read the full story

Thursday, February 14, 2019

Rodan & Fields Takes on Teen Acne with Spotless

Rodan & Fields is launching Spotless, a patent-pending teen and young adult acne solution. The company is also updating its Unblemish Regimen with new formulas that feature Benzoyl Peroxide a…

Read the full story

Friday, February 01, 2019

Vyome Secures $22M to Advance Dermatology Pipeline

Vyome Therapeutics Inc., a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, closed $22 million in financing.&nbs…

Read the full story

Thursday, January 17, 2019

Almirall's Seysara Now Available

SeysaraTM (sarecycline), a novel tetracycline-derived oral antibiotic developed specifically for the treatment of acne, is now commercially available from Almirall. Seysara™ was approved in…

Read the full story

Wednesday, January 16, 2019

Dermatologists Prescribe the Most Antibiotics, But Usage Is Changing

The use of antibiotics to treat inflammatory skin conditions like acne and rosacea is decreasing over time, but there has been an increase in prescriptions associated with dermatologic surgical proced…

Read the full story

Friday, November 30, 2018

Crown Laboratories Acquires Select Healthcare Brands from GlaxoSmithKline

Crown Laboratories, Inc. has acquired North American distribution rights of five OTC consumer brands from GlaxoSmithKline (GSK). The acquired portfolio includes: PanOxyl® daily acne wash…

Read the full story

Thursday, November 29, 2018

Cosmetic Surgery Forum Kicks Off in Las Vegas

With new and returning faculty, controversial and timely topics, and an all new venue, Cosmetic Surgery Forum (CSF) kicks off its 10th year at the chic Cosmopolitan Hotel. The meeting features 50 sess…

Read the full story

Tuesday, October 30, 2018

Ortho Dermatologics' Altreno Now Available in the US

Ortho Dermatologics launched Altreno (tretinoin) Lotion, 0.05% for the topical treatment of acne vulgaris in patients 9 years of age and older. Altreno Lotion is the first and only tretinoin available…

Read the full story

Tuesday, October 23, 2018

Almirall, LLC is the New Name of Aqua

Almirall, LLC is the new name of Aqua Pharmaceuticals. Almirall, LLC is part of the larger Almirall, S.A. family, an internationally-recognized global dermatology pharmaceutical company, wit…

Read the full story

Thursday, October 18, 2018

Almirall’s Seysara Set to Shake Up US Acne Market

The US Food and Drug Administration’s approval of Almirall’s Seysara (sarecycline) for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients age…

Read the full story

Thursday, October 11, 2018

Pre-conditioning Added to Sebacia Microparticles Enhances Outcomes

Using pre-conditioning in conjunction with Sebacia Microparticles for treatment of acne leads to enhanced outcomes, new data suggest. In fact, results from a real-world, pre-conditioning registry tria…

Read the full story
Load More